Intrinsic Alpha

Clover Health Investments, Corp.

NASDAQ:CLOV

Medical - Healthcare Plans

Healthcare
$3.73 +3.54%

+$0.17 today

Market cap
$1.98B
Beta
2.48
P/E (TTM)
-45.6
EPS (TTM)
-$0.11
52W Low $1.58High $5.18

Volume 7.24M

Average 7.31M

Income Statement

Follow revenue through to earnings.

Revenue

$1.92B

FY 2025 · Annual

+40.3% YoY

Operating Income

-$85.53M

FY 2025 · Annual

Net Income

-$85.55M

FY 2025 · Annual

Income Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Revenue1.47B1.1B1.26B1.37B1.92B
Cost of Revenue1.55B993.07M1B1.01B1.57B
Gross Profit(79.18M)103.48M255.95M364.8M355.88M
Gross Margin-5.4%9.4%20.3%26.6%18.5%
Research & Development00000
Selling, General & Admin445.75M482.4M440.25M408.93M176.32M
Operating Expenses557.81M390.14M461.28M410.55M441.43M
Depreciation & Amortization1.25M1.19M2.51M1.33M1.69M
EBITDA(569.6M)(252.03M)(207.63M)(44.94M)(83.86M)
EBITDA Margin-38.7%-23.0%-16.5%-3.3%-4.4%
Operating Income(636.99M)(286.66M)(205.33M)(45.75M)(85.53M)
Operating Margin-43.3%-26.1%-16.3%-3.3%-4.4%
Interest Income00000
Interest Expense16.91M1.36M7K00
Other Income / Expenses49.24M32.08M(4.82M)(517K)(20K)
Income Before Tax(587.76M)(254.58M)(210.15M)(46.27M)(85.55M)
Pre-Tax Margin-39.9%-23.2%-16.7%-3.4%-4.4%
Income Tax Expense00000
Net Income(587.76M)(339.57M)(213.36M)(43.01M)(85.55M)
Net Margin-39.9%-31.0%-16.9%-3.1%-4.4%
EPS (Basic)(1.25)(0.71)(0.45)(0.09)(0.17)
EPS (Diluted)(1.25)(0.71)(0.45)(0.09)(0.17)
Weighted Avg Shares470.85M476.24M482.18M490.02M517.24M
Weighted Avg Shares (Diluted)470.85M476.24M482.18M490.02M517.24M

CLOV Earnings Waterfall · TTM

NASDAQ:CLOV · Revenue to Net Income

Key Ratios

EPS$-0.04
Gross Margin18.0%
Net Margin-1.9%
P/E Ratio3.1
P/S Ratio2.6

Analysis

$2.5B of revenue converted into -$18.4M of net income for the selected period. Gross margin is 18.0% and net margin is -1.9%, showing how much revenue survives after costs and taxes. EPS is $-0.04, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 6, 2026
4Statement of changes in beneficial ownershipNov 6, 2026
10-QQuarterly reportNov 6, 2026
8-KCurrent reportNov 4, 2026
4Statement of changes in beneficial ownershipOct 20, 2026

How much revenue does CLOV generate?

Clover Health Investments, Corp. (CLOV) reported $1.92B of revenue in fiscal 2025.

Is CLOV profitable?

Clover Health Investments, Corp. (CLOV) reported -$85.55M of net income, with a net margin of -4.4%.